Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 2/2024

Open Access 06-11-2023 | Postthrombotic Syndrome

Incidence and predictors of post-thrombotic syndrome in patients with proximal DVT in a real-world setting: findings from the GARFIELD-VTE registry

Authors: Paolo Prandoni, Sylvia Haas, Meg E. Fluharty, Sebastian Schellong, Harry Gibbs, Eric Tse, Marc Carrier, Barry Jacobson, Hugo ten Cate, Elizaveta Panchenko, Peter Verhamme, Karen Pieper, Gloria Kayani, Lord A. Kakkar, the GARFIELD-VTE investigators

Published in: Journal of Thrombosis and Thrombolysis | Issue 2/2024

Login to get access

Abstract

Although substantial progress has been made in the pathophysiology and management of the post-thrombotic syndrome (PTS), several aspects still need clarification. Among them, the incidence and severity of PTS in the real world, the risk factors for its development, the value of patient’s self-evaluation, and the ability to identify patients at risk for severe PTS. Eligible participants (n = 1107) with proximal deep-vein thrombosis (DVT) from the global GARFIELD-VTE registry underwent conventional physician’s evaluation for PTS 36 months after diagnosis of their DVT using the Villalta score. In addition, 856 patients completed a Villalta questionnaire at 24 months. Variable selection was performed using stepwise algorithm, and predictors of severe PTS were incorporated into a multivariable risk model. The optimistic adjusted c-index was calculated using bootstrapping techniques. Over 36-months, 27.8% of patients developed incident PTS (mild in 18.7%, moderate in 5.7%, severe in 3.4%). Patients with incident PTS were older, had a lower prevalence of transient risk factors of DVT and a higher prevalence of persistent risk factors of DVT. Self-assessment of overall PTS at 24 months showed an agreement of 63.4% with respect to physician’s evaluations at 36 months. The severe PTS multivariable model provided an optimistic adjusted c-index of 0.68 (95% CI 0.59–0.77). Approximately a quarter of DVT patients experienced PTS over 36 months after VTE diagnosis. Patient’s self-assessment after 24 months provided added value for estimating incident PTS over 36 months. Multivariable risk analysis allowed good discrimination for severe PTS.
Appendix
Available only for authorised users
Literature
1.
go back to reference Prandoni P, Lensing AW, Cogo A, Cuppini S, Villalta S, Carta M, Cattelan AM, Polistena P, Bernardi E, Prins MH (1996) The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 125:1–7CrossRefPubMed Prandoni P, Lensing AW, Cogo A, Cuppini S, Villalta S, Carta M, Cattelan AM, Polistena P, Bernardi E, Prins MH (1996) The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 125:1–7CrossRefPubMed
2.
go back to reference Kahn SR, Shrier I, Julian JA, Ducruet T, Arsenault L, Miron MJ, Roussin A, Desmarais S, Joyal F, Kassis J, Solymoss S, Desjardins L, Lamping DL, Johri M, Ginsberg JS (2008) Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med 149:698–707CrossRefPubMed Kahn SR, Shrier I, Julian JA, Ducruet T, Arsenault L, Miron MJ, Roussin A, Desmarais S, Joyal F, Kassis J, Solymoss S, Desjardins L, Lamping DL, Johri M, Ginsberg JS (2008) Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med 149:698–707CrossRefPubMed
3.
go back to reference Kahn SR, Shapiro S, Wells PS, Rodger MA, Kovacs MJ, Anderson DR, Tagalakis V, Houweling AH, Ducruet T, Holcroft C, Johri M, Solymoss S, Miron MJ, Yeo E, Smith R, Schulman S, Kassis J, Kearon C, Chagnon I, Wong T, Demers C, Hanmiah R, Kaatz S, Selby R, Rathbun S, Desmarais S, Opatrny L, Ortel TL, Ginsberg JS, SOX trial investigators (2014) Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial. Lancet 383:880–888CrossRefPubMed Kahn SR, Shapiro S, Wells PS, Rodger MA, Kovacs MJ, Anderson DR, Tagalakis V, Houweling AH, Ducruet T, Holcroft C, Johri M, Solymoss S, Miron MJ, Yeo E, Smith R, Schulman S, Kassis J, Kearon C, Chagnon I, Wong T, Demers C, Hanmiah R, Kaatz S, Selby R, Rathbun S, Desmarais S, Opatrny L, Ortel TL, Ginsberg JS, SOX trial investigators (2014) Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial. Lancet 383:880–888CrossRefPubMed
4.
go back to reference Amin EE, Ten Cate-Hoek AJ, Bouman AC, Meijer K, Tick L, Middeldorp S, Mostard G, Ten Wolde M, van den Heiligenberg S, van Wissen S, van de Poel M, Villalta S, Serné E, Otten HM, Klappe E, Prandoni P, Prins MH, Ten Cate H, Joore MA (2018) Individually shortened duration versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome: a cost-effectiveness analysis. Lancet Haematol 5:e512–e519CrossRefPubMed Amin EE, Ten Cate-Hoek AJ, Bouman AC, Meijer K, Tick L, Middeldorp S, Mostard G, Ten Wolde M, van den Heiligenberg S, van Wissen S, van de Poel M, Villalta S, Serné E, Otten HM, Klappe E, Prandoni P, Prins MH, Ten Cate H, Joore MA (2018) Individually shortened duration versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome: a cost-effectiveness analysis. Lancet Haematol 5:e512–e519CrossRefPubMed
5.
go back to reference Kahn SR, Partsch H, Vedantham S, Prandoni P, Kearon C, Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis (2009) Definition of post-thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization. J Thromb Haemost 7:879–883CrossRefPubMed Kahn SR, Partsch H, Vedantham S, Prandoni P, Kearon C, Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis (2009) Definition of post-thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization. J Thromb Haemost 7:879–883CrossRefPubMed
6.
go back to reference Kahn SR, Comerota AJ, Cushman M, Evans NS, Ginsberg JS, Goldenberg NA, Gupta DK, Prandoni P, Vedantham S, Walsh ME, Weitz JI, American Heart Association Council on Peripheral Vascular Disease, Council on Clinical Cardiology, and Council on Cardiovascular and Stroke Nursing (2014) The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation 130:1636–1661CrossRefPubMed Kahn SR, Comerota AJ, Cushman M, Evans NS, Ginsberg JS, Goldenberg NA, Gupta DK, Prandoni P, Vedantham S, Walsh ME, Weitz JI, American Heart Association Council on Peripheral Vascular Disease, Council on Clinical Cardiology, and Council on Cardiovascular and Stroke Nursing (2014) The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation 130:1636–1661CrossRefPubMed
7.
go back to reference Visonà A, Quere I, Mazzolai L, Amitrano M, Lugli M, Madaric J, Prandoni P (2021) European Society of Vascular Medicine (ESVM). Post-thrombotic syndrome. Vasa 50:331–340CrossRefPubMed Visonà A, Quere I, Mazzolai L, Amitrano M, Lugli M, Madaric J, Prandoni P (2021) European Society of Vascular Medicine (ESVM). Post-thrombotic syndrome. Vasa 50:331–340CrossRefPubMed
8.
go back to reference Tritschler T, Kraaijpoel N, Le Gal G, Wells PS (2018) Venous thromboembolism: advances in diagnosis and treatment. JAMA 320:1583–1594CrossRefPubMed Tritschler T, Kraaijpoel N, Le Gal G, Wells PS (2018) Venous thromboembolism: advances in diagnosis and treatment. JAMA 320:1583–1594CrossRefPubMed
9.
go back to reference Ageno W, Haas S, Weitz JI, Goldhaber SZ, Turpie AGG, Goto S, Angchaisuksiri P, Nielsen JD, Kayani G, Pieper KS, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK, GARFIELD-VTE investigators (2019) Characteristics and management of patients with venous thromboembolism: the GARFIELD-VTE Registry. Thromb Haemost 119:319–327CrossRefPubMed Ageno W, Haas S, Weitz JI, Goldhaber SZ, Turpie AGG, Goto S, Angchaisuksiri P, Nielsen JD, Kayani G, Pieper KS, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK, GARFIELD-VTE investigators (2019) Characteristics and management of patients with venous thromboembolism: the GARFIELD-VTE Registry. Thromb Haemost 119:319–327CrossRefPubMed
10.
go back to reference Bergqvist D, Jendteg S, Johansen L, Persson U, Ödegaard K (1997) Cost of long term complications of deep venous thrombosis of the lower extremities: an analysis of a defined patient population in Sweden. Ann Intern Med 126:454–457CrossRefPubMed Bergqvist D, Jendteg S, Johansen L, Persson U, Ödegaard K (1997) Cost of long term complications of deep venous thrombosis of the lower extremities: an analysis of a defined patient population in Sweden. Ann Intern Med 126:454–457CrossRefPubMed
11.
go back to reference Kahn SR, M’Lan CE, Lamping DL, Kurz X, Bérard A, Abenhaim L (2004) The influence of venous thromboembolism on quality of life and severity of chronic venous disease. J Thromb Haemost 2:2146–2151CrossRefPubMed Kahn SR, M’Lan CE, Lamping DL, Kurz X, Bérard A, Abenhaim L (2004) The influence of venous thromboembolism on quality of life and severity of chronic venous disease. J Thromb Haemost 2:2146–2151CrossRefPubMed
12.
go back to reference Prandoni P, Farjat AE, Haas S, Turpie AG, Bounameaux H, Schellong S, Goldhaber SZ, Kayani G, Carrier M, Jacobson B, Ageno W, Weitz JI, Goto S, Angchaisuksiri P, Mantovani LG, Kakkar AK (2021) Incidence and predictors of post-thrombotic syndrome: results from GARFIELD-VTE [abstract]. Res Pract Thromb Haemost 5(Suppl 2) Prandoni P, Farjat AE, Haas S, Turpie AG, Bounameaux H, Schellong S, Goldhaber SZ, Kayani G, Carrier M, Jacobson B, Ageno W, Weitz JI, Goto S, Angchaisuksiri P, Mantovani LG, Kakkar AK (2021) Incidence and predictors of post-thrombotic syndrome: results from GARFIELD-VTE [abstract]. Res Pract Thromb Haemost 5(Suppl 2)
16.
go back to reference Nishimoto Y, Yamashita Y, Morimoto T, Saga S, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Shiomi H, Kato T, Makiyama T, Ono K, Sato Y, Kimura T, COMMAND VTE Registry Investigators (2019) Risk factors for post-thrombotic syndrome in patients with deep vein thrombosis: from the COMMAND VTE registry. Heart Vessels. 34(4):669–677. https://doi.org/10.1007/s00380-018-1277-3CrossRefPubMed Nishimoto Y, Yamashita Y, Morimoto T, Saga S, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Shiomi H, Kato T, Makiyama T, Ono K, Sato Y, Kimura T, COMMAND VTE Registry Investigators (2019) Risk factors for post-thrombotic syndrome in patients with deep vein thrombosis: from the COMMAND VTE registry. Heart Vessels. 34(4):669–677. https://​doi.​org/​10.​1007/​s00380-018-1277-3CrossRefPubMed
17.
go back to reference Utne KK, Ghanima W, Foyn S, Kahn S, Sandset PM, Wik HS (2016) Development and validation of a tool for patient reporting of symptoms and signs of the post-thrombotic syndrome. Thromb Haemost 115:361–367CrossRefPubMed Utne KK, Ghanima W, Foyn S, Kahn S, Sandset PM, Wik HS (2016) Development and validation of a tool for patient reporting of symptoms and signs of the post-thrombotic syndrome. Thromb Haemost 115:361–367CrossRefPubMed
18.
go back to reference Rabinovich A, Ducruet T, Kahn SR, SOX Trial investigators (2018) Development of a clinical prediction model for the postthrombotic syndrome in a prospective cohort of patients with proximal deep vein thrombosis. J Thromb Haemost 16:262–270CrossRefPubMed Rabinovich A, Ducruet T, Kahn SR, SOX Trial investigators (2018) Development of a clinical prediction model for the postthrombotic syndrome in a prospective cohort of patients with proximal deep vein thrombosis. J Thromb Haemost 16:262–270CrossRefPubMed
19.
go back to reference Rabinovich A, Gu CS, Vedantham S, Kearon C, Goldhaber SZ, Gornik HL, Kahn SR, ATTRACT Trial Investigators (2020) External validation of the SOX-PTS score in a prospective multicenter trial of patients with proximal deep vein thrombosis. J Thromb Haemost 18:1381–1389CrossRefPubMedPubMedCentral Rabinovich A, Gu CS, Vedantham S, Kearon C, Goldhaber SZ, Gornik HL, Kahn SR, ATTRACT Trial Investigators (2020) External validation of the SOX-PTS score in a prospective multicenter trial of patients with proximal deep vein thrombosis. J Thromb Haemost 18:1381–1389CrossRefPubMedPubMedCentral
20.
go back to reference Amin EE, van Kuijk SMJ, Joore MA, Prandoni P, Cate HT, Cate-Hoek AJT (2018) Development and validation of a practical two-step prediction model and clinical risk score for post-thrombotic syndrome. Thromb Haemost 118:1242–1249CrossRefPubMed Amin EE, van Kuijk SMJ, Joore MA, Prandoni P, Cate HT, Cate-Hoek AJT (2018) Development and validation of a practical two-step prediction model and clinical risk score for post-thrombotic syndrome. Thromb Haemost 118:1242–1249CrossRefPubMed
21.
go back to reference Zhang J, Ma F, Yao J, Hao B, Xu H, Guo X, Gao H, Yang T (2022) Development and validation of a clinical prediction model for post thrombotic syndrome following anticoagulant therapy for acute deep venous thrombosis. Thromb Res 214:68–75CrossRefPubMed Zhang J, Ma F, Yao J, Hao B, Xu H, Guo X, Gao H, Yang T (2022) Development and validation of a clinical prediction model for post thrombotic syndrome following anticoagulant therapy for acute deep venous thrombosis. Thromb Res 214:68–75CrossRefPubMed
Metadata
Title
Incidence and predictors of post-thrombotic syndrome in patients with proximal DVT in a real-world setting: findings from the GARFIELD-VTE registry
Authors
Paolo Prandoni
Sylvia Haas
Meg E. Fluharty
Sebastian Schellong
Harry Gibbs
Eric Tse
Marc Carrier
Barry Jacobson
Hugo ten Cate
Elizaveta Panchenko
Peter Verhamme
Karen Pieper
Gloria Kayani
Lord A. Kakkar
the GARFIELD-VTE investigators
Publication date
06-11-2023
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 2/2024
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-023-02895-7

Other articles of this Issue 2/2024

Journal of Thrombosis and Thrombolysis 2/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine